Gomes Lab

@gomeslab.bsky.social

We are focused on understanding how aging and other factors that shape host physiology regulate cancer progression, evolution and treatment responses https://lab.moffitt.org/gomes/

Honored to be recognized as the Research Educator of the Year. A PI’s real legacy isn’t just the papers they publish or the grants they win, it’s the people they mentor, the scientists, thinkers, and leaders who carry forward the values, curiosity, and rigor they helped cultivate

BildBild

So happy to share the newest pre-print from the lab where we show that old age significantly changes the traits that evolve in established lung adenocarcinoma. This work sheds light into the importance of modeling age-related cancers in the context of old age. www.biorxiv.org/content/10.1...

Aging directs the differential evolution of KRAS-driven lung adenocarcinoma

Lung adenocarcinoma (LUAD), the most common histological subtype of lung cancer( [1][1], [2][2] ), is a disease of the elderly, with an average age of diagnosis of about 70 years of age( [3][3] ). Old...

biorxiv.org

🦋Introductory post 🦋 The Metastasis Research Society (MRS) is a professional society for metastasis researchers. The MRS is dedicated to promoting research into all aspects of metastasis, and the exchange of information amongst key stakeholders including scientists, clinicians & patients.

Mind blowing talk by James DeGregori on viral infection, awakening, and maintenance of metastatic outgrowth. Not good news for those of us that have had multiple Covid-19 infections. #AACRtumorenviron24

Bild

Super happy to share our lab new paper spearheaded by graduate student Joanne Tejero describing a role for the age-induced oncometabolite methylamlonic acid in promoting T cell exhaustion and contributing to lung cancer immune evasion. www.nature.com/articles/s41...

Methylmalonic acid induces metabolic abnormalities and exhaustion in CD8+ T cells to suppress anti-tumor immunity - Oncogene

Oncogene - Methylmalonic acid induces metabolic abnormalities and exhaustion in CD8+ T cells to suppress anti-tumor immunity

nature.com